LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-525 Cr | ₹39 Cr | ₹250 Cr | ₹-27 Cr | ₹30 Cr |
What is the latest Cash Flow from Financing Activities ratio of LAURUS LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-525 Cr |
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹250 Cr |
| Mar2023 | ₹-27 Cr |
| Mar2022 | ₹30 Cr |
How is Cash Flow from Financing Activities of LAURUS LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-525 Cr | Negative | |
| Mar2025 | ₹39 Cr | -84.28 | |
| Mar2024 | ₹250 Cr | Positive | |
| Mar2023 | ₹-27 Cr | Negative | |
| Mar2022 | ₹30 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹106,114.9 Cr | -2.4% | 5.4% | 138.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -2.4% |
5.4% |
138.9% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses